Dose-escalation Study to Investigate the Safety, PK, and PD of ISU304/CB2679d in Hemophilia B Patients
Clinical trial NCT03186677 · COMPLETED
Trial details
- NCT number
- NCT03186677
- Sponsor
- ISU Abxis Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-03
- Primary completion
- 2018-10-10
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.